Chinese pharmaceutical and investment companies are actively involved in international mergers and acquisitions, contributing to market internationalization. China's pharmaceutical manufacturers focus on producing basic chemicals, intermediates, and active pharmaceutical ingredients (APIs), with around 4,000 API manufacturers in the country. This trend is driving the market's expansion and innovation. The pandemic has accelerated the adoption of telemedicine and e-pharmacies, enabling remote consultations and medication delivery, especially in regions with limited access to healthcare facilities.
Access Full Report @ https://www.databridgemarketresearch.com/reports/china-hospitals-and-pharmacy-market
Data Bridge Market Research analyses that the China Hospitals and Pharmacy Market is expected to grow to USD 1,471.23 million in 2022 and would grow to USD 3,774.85 million by 2030, with a CAGR of around 12.5% during the forecast period from 2023 to 2030. The increasing adoption of medical automation techniques, including robotic-assisted systems in hospitals, enhances efficiency and patient care, driving market growth.
Key Findings of the Study
Increasing healthcare demand is expected to drive the market's growth rate
China's large and aging population has led to an increasing demand for healthcare services, including hospitals and pharmacy facilities. The rising prevalence of chronic diseases and the need for quality medical care drive the demand for accessible healthcare services. As a result, the hospitals and pharmacy market in China is experiencing significant growth, presenting opportunities for expansion and investment in the healthcare sector to meet the growing needs of the population.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Component (Equipment, Software, and Services), Type (Automated Prescription Formulation and Dispensing, Automated Health Assessment and Monitoring, Automated Imaging, and Image Analysis, Automated Healthcare Logistics, Resource and Personnel Tracking, Medical Robotics and Computer-Assisted Surgical Devices, Automated Therapeutic (Nonsurgical) Procedures, Automated Laboratory Testing, and Analysis), Application (Diagnostics and Monitoring, Therapeutics, Lab and Pharmacy Automation, Medical Logistics and Training, and Others), Connectivity (Wired and Wireless), End User (Hospitals, Pharmacies), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others)
|
|
Market Players Covered
|
Baxter (U.S.), Takazono Corporation (Japan), TOSHO CO., INC.(Japan), YUYAMA Co., Ltd / YUYAMA MFG Co., Ltd (Japan)., Shandong New Beiyang Information Technology Co., Ltd (China), Asahi Kasei Corporation (Tokyo), Intuitive Surgical (U.S.), Medtronic (Ireland), Stryker (U.S.), Omnicell, Inc (U.S.)., B.D. (U.S.), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V.(Netherlands), G.E. Healthcare (U.S.), and Johnson & Johnson Services, Inc. (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The China hospitals and pharmacy market is segmented on the basis of component, type, application, connectivity, end user and distribution channel
- On the basis of component, the China hospitals and pharmacy market is segmented into equipment, software, and services.
- On the basis of type, the China hospitals and pharmacy market is segmented into automated prescription formulation and dispensing, automated health assessment and monitoring, automated imaging, and image analysis, automated healthcare logistics, resource and personnel tracking, medical robotics and computer-assisted surgical devices, automated therapeutic (nonsurgical) procedures, automated laboratory testing, and analysis.
- On the basis of application, the China hospitals and pharmacy market is segmented into diagnostics and monitoring, therapeutics, lab and pharmacy automation, medical logistics and training, and others.
- On the basis of connectivity, the China hospitals and pharmacy market is segmented into wired and wireless.
- On the basis of end user, the China hospitals and pharmacy market is segmented into hospitals, pharmacies.
- On the basis of distribution channel, the China hospitals and pharmacy market is segmented into direct tender, retail sales, online sales, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major China hospitals and pharmacy market players in China hospitals and pharmacy market are Shandong New Beiyang Information Technology Co., Ltd (China), Asahi Kasei Corporation (Tokyo), Intuitive Surgical (U.S.), Medtronic (Ireland), Stryker (U.S.), Omnicell, Inc (U.S.)., B.D. (U.S.), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V.(Netherlands)
Market Development
- In 2020, Ai Linghang, launched by Shanghai Qiyou Precision Electromechanical Co., Ltd., was showcased at the Arab Health 2020 held in Dubai. The people witnessed the new technologically sound pill packaging machine combined with a pill box and an alarm system which will reduce the huge pill packaging process.
For more detailed information about the China hospitals and pharmacy market report, click here – https://www.databridgemarketresearch.com/reports/china-hospitals-and-pharmacy-market
